f.h. faulding & co. , an australian pharmaceuticals company , said 0 its moleculon inc. affiliate acquired kalipharma inc. for $ 23 million . kalipharma is a new jersey-based pharmaceuticals concern that sells products under the purepac label . faulding said 0 it owns 33 % of moleculon 's voting stock and has an agreement to acquire an additional 19 % . that stake , together with its convertible preferred stock holdings , gives faulding the right to increase its interest to 70 % of moleculon 's voting stock .